BMJ Open Acceptance Rate
BMJ Open acceptance rate is about 27%. Use it as a selectivity signal, then sanity-check scope, editorial fit, and submission timing.
Journal evaluation
Want the full picture on BMJ Open?
See scope, selectivity, submission context, and what editors actually want before you decide whether BMJ Open is realistic.
What BMJ Open's acceptance rate means for your manuscript
Acceptance rate is one signal. Desk rejection rate, scope fit, and editorial speed shape the realistic path more than the headline number.
What the number tells you
- BMJ Open accepts roughly 27% of submissions, but desk rejection accounts for a disproportionate share of early returns.
- Scope misfit drives most desk rejections, not weak methodology.
- Papers that reach peer review face a higher bar: novelty and fit with editorial identity.
What the number does not tell you
- Whether your specific paper type (review, letter, brief communication) faces the same rate as full articles.
- How fast you will hear back — check time to first decision separately.
- What open access costs — £2,390 GBP for gold OA.
Quick answer: BMJ Open currently reports a 27% acceptance rate on its official journal statistics page. That is lower than many authors assume for a broad medical open-access journal. The more useful planning point is that BMJ Open still operates as a soundness-led venue: the paper does not need to be practice-changing, but it does need a defensible design, clean reporting, and clear relevance to a broad medical readership.
The BMJ Open journal page is the best cluster reference if you want to compare this acceptance-rate signal against fit, review time, and APC context.
BMJ Open acceptance-rate context at a glance
Metric | Current figure | Why it matters |
|---|---|---|
Official acceptance rate | 27% | Current journal-reported selectivity signal |
Time to first decision with review | 134 days | Useful expectation-setting for full review |
Impact factor (2024) | 2.3 | Broad-medicine citation position |
CiteScore | 4.5 | Scopus-side context |
Review model | Soundness-led, open peer review | Fit matters more than novelty framing |
Journal model | Fully open access | APC applies after acceptance |
That table gives the honest answer. BMJ Open is not a fallback where anything methodologically decent goes through. A 27% acceptance rate means the journal is filtering harder than many broad-scope OA medical journals, even though it is not screening for the same prestige signals as BMJ, JAMA, or NEJM.
Longer-term metrics context
Year | Impact factor |
|---|---|
2017 | 2.4 |
2018 | 2.4 |
2019 | 2.5 |
2020 | 2.7 |
2021 | 4.4 |
2022 | 2.8 |
2023 | 2.4 |
2024 | 2.3 |
The 2024 impact factor is down from 2.4 in 2023 to 2.3 in 2024. That is not a special warning sign. It is the continuation of post-pandemic normalization after the 2021 spike. BMJ Open is back in its normal citation band, which is exactly how authors should plan around it.
How BMJ Open compares with nearby journals
Journal | Acceptance signal | IF (2024) | Secondary metrics signal | Best fit |
|---|---|---|---|---|
BMJ Open | 27% official | 2.3 | CiteScore 4.5 | Sound methods across broad medicine |
PLOS ONE | Public estimates only | 2.6 | Broad multidisciplinary soundness model | Strong if the audience is not specifically medical |
Scientific Reports | Approx. 50% from Nature board guidance | 3.9 | Higher scale and broader science reach | Better for cross-disciplinary science beyond medicine |
BMJ | Much more selective | 93.6 | Flagship general-medicine prestige | Practice-changing clinical work |
JAMA Network Open | More selective | 9.7 | Stronger citation and brand signal | High-consequence clinical or public-health work |
The practical point is simple: BMJ Open is not trying to be BMJ Open because it is easier than BMJ. It is a different editorial model. If the paper's main strength is rigor, completeness, and usefulness rather than immediate field-changing consequence, BMJ Open can be the right home.
What the 27% acceptance rate really means
The acceptance rate tells you BMJ Open is selective enough that authors should stop treating it like a low-bar megajournal. It does not mean the journal is secretly prestige-driven.
What it tells you:
- the editorial screen is real
- broad-scope does not mean permissive on weak methods
- the journal has room to reject incomplete or poorly framed work early
What it does not tell you:
- how many of the rejections are desk decisions versus full-review rejections
- how protocols, observational studies, systematic reviews, and qualitative work behave relative to each other
- whether the main problem is methodology, ethics documentation, or simple scope mismatch
That is why the number helps with orientation, but not with final targeting.
What BMJ Open editors are actually screening for
The official pages and the review culture point to a consistent first-pass screen:
- Is the study design appropriate to the question?
- Is reporting complete enough for open peer review?
- Are ethics, consent, registration, and data-availability statements in order?
- Does the paper matter to a broad medical or public-health readership, even if it is not a prestige-journal story?
Open peer review matters here. BMJ Open publishes reviewer reports and earlier manuscript versions with accepted papers. That means weak reporting or slippery framing is harder to hide than in a conventional closed-review model.
Readiness check
See how your manuscript scores against BMJ Open before you submit.
Run the scan with BMJ Open as your target journal. Get a fit signal alongside the IF context.
What we see in pre-submission review work
In our pre-submission review work, BMJ Open submissions fail for reasons that are usually more concrete than authors expect.
Checklist compliance is claimed but not actually implemented. We see STROBE, CONSORT, PRISMA, or COREQ checklists attached to the submission package, but the manuscript itself still lacks key required details. BMJ Open is more likely than many authors expect to treat that gap as a real editorial problem rather than a formality issue.
Observational studies overclaim. A technically competent cohort, cross-sectional, or registry study often gets into trouble when the Results and Discussion drift into causal language that the design cannot support.
Ethics and transparency sections are underbuilt. Missing committee names, absent approval numbers, vague consent language, or weak data-sharing statements are repeated early failure modes.
That is why the acceptance-rate question is only half the story. For BMJ Open, the live issue is often not whether the paper is exciting enough. It is whether the manuscript is clean enough.
The better submission question
For BMJ Open, the better decision question is:
Is this manuscript methodologically sound, transparently reported, and framed with conclusions the design can actually support?
If yes, the 27% acceptance rate is a serious but realistic hurdle. If no, the rate is not the bottleneck. The manuscript package is.
Submit if / Think twice if
Submit if:
- the study design clearly matches the question
- reporting-guideline requirements are actually implemented in the manuscript
- ethics, registration, consent, and data-availability sections are complete
- the paper is solid and useful even if it is not a prestige-journal headline
Think twice if:
- the paper really needs BMJ, JAMA Network Open, or another more selective medical venue first
- the manuscript still overstates causal or clinical implications
- the submission package is relying on checklists to patch weak methods reporting
- the topic is so narrow that a specialty journal would serve the audience better
Practical verdict
The live official answer is straightforward: BMJ Open currently reports a 27% acceptance rate.
The better operating answer is:
- BMJ Open is selective enough that sloppy submissions get filtered
- the journal still evaluates more on soundness than on prestige signaling
- authors should treat reporting completeness and design discipline as the real decision surface
If you want to pressure-test whether the manuscript actually behaves like a BMJ Open paper before submission, a BMJ Open submission readiness check is the best next step.
Frequently asked questions
BMJ Open's current journal statistics page reports a 27% acceptance rate. That is a live official figure and more useful than the rough third-party estimates still circulating online.
Methodological soundness, reporting completeness, ethics documentation, and whether the manuscript fits a broad medical readership. BMJ Open does not reject for lack of glamour, but it does reject for weak design or incomplete reporting.
BMJ Open currently reports a 2024 impact factor of 2.3 and a CiteScore of 4.5. Those numbers place it as a credible broad medical open-access journal, not a flagship general-medicine venue.
BMJ Open is the soundness-led companion venue. BMJ and JAMA Network Open are much more selective on perceived clinical consequence and broader narrative significance.
A paper that is methodologically incomplete rather than merely unexciting. Missing reporting-guideline compliance, weak ethics documentation, and overclaimed observational findings are repeated reasons manuscripts fail.
Sources
Before you upload
Want the full picture on BMJ Open?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Is BMJ Open a Good Journal? An Honest Assessment
- BMJ Open Submission Guide
- BMJ Open Review Time: What Authors Can Actually Expect
- How to Avoid Desk Rejection at BMJ Open
- BMJ Open Impact Factor 2026: 2.3 - What That Number Actually Means for Your Paper
- BMJ Open Pre Submission Checklist: 12 Items Editors Verify Before Peer Review
Compare alternatives
Supporting reads
Conversion step
Want the full picture on BMJ Open?
These pages attract evaluation intent more than upload-ready intent.